Pages that link to "Q42132275"
Jump to navigation
Jump to search
The following pages link to Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy (Q42132275):
Displaying 11 items.
- Erythropoietin: new directions for the nervous system (Q26828425) (← links)
- Animal modeling an oligodendrogliopathy--multiple system atrophy (Q28074659) (← links)
- PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection (Q34429082) (← links)
- Erythropoietin Employs Cell Longevity Pathways of SIRT1 to Foster Endothelial Vascular Integrity During Oxidant Stress (Q35146283) (← links)
- Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia (Q35663684) (← links)
- Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL. (Q35947388) (← links)
- New insights into atypical parkinsonism. (Q37876156) (← links)
- New horizons in the pathogenesis, assessment and management of movement disorders. (Q38036239) (← links)
- Multiple system atrophy of the cerebellar type: clinical state of the art. (Q38194974) (← links)
- Long-term moderate dose exogenous erythropoietin treatment protects from intermittent hypoxia-induced spatial learning deficits and hippocampal oxidative stress in young rats. (Q45976217) (← links)
- Erythropoietin and Friedreich Ataxia: Time for a Reappraisal? (Q64093623) (← links)